|1.||Nishida, Teruo: 5 articles (05/2011 - 01/2008)|
|2.||Teranishi, Shinichiro: 4 articles (05/2011 - 01/2008)|
|3.||Kimura, Kazuhiro: 4 articles (05/2011 - 01/2008)|
|4.||Wen, Hao: 3 articles (01/2015 - 12/2010)|
|5.||Nascimento, Flávia R F: 3 articles (01/2015 - 04/2007)|
|6.||Silva, Lucilene A: 3 articles (01/2015 - 04/2007)|
|7.||Kawamoto, Koji: 3 articles (05/2011 - 06/2008)|
|8.||Li, Haitao: 2 articles (02/2015 - 01/2014)|
|9.||Pereira, Wanderson S: 2 articles (01/2015 - 01/2008)|
|10.||Aji, Tuerganaili: 2 articles (01/2014 - 12/2010)|
01/01/2015 - "The HCE tissue culture may be used as an in vitro model to study environmental exposure induced eye irritation and inflammation."
04/28/2014 - "The present study extends earlier works on the role of anti-inflammation in regulating the antidepressant-like actions of HCE in rats exposed to chronic unpredictable mild stress (CUMS). "
01/01/2014 - "RV-D1 may serve as a potent anti-inflammatory agent in ocular surface inflammation, as evaluated in cultured HCE cells. "
04/01/2008 - "Taken together with results from HCE cells, these findings demonstrate that JNK has an essential role in TLR2-induced corneal inflammation."
01/01/2015 - "ambrosioides HCE was effective in the treatment of OA because it reduced synovial inflammation and behavioral changes due to pain. "
10/01/2012 - "HCE in periampullary cancer is safe and effective in selected patients. "
02/01/2013 - "This study was designed to examine the in vitro antiproliferative effect of the horse chestnut extract (HCE) on cancer cell lines. "
05/01/2014 - "Reducing the variation in outcomes associated with HCE may improve the quality of cancer care."
02/01/2013 - "Incubation of Jurkat, CEM, HeLa, and MCF-7 cancer cells with HCE at 125 µg/mL for 72 h caused 93.7%, 32.3%, 20.4% and 40.4% reduction in cell survival. "
10/01/2012 - "All patients undergoing HCE for the management of periampullary cancer were identified from a prospectively maintained computerised database of a single surgeon and were reviewed retrospectively. "
01/01/2014 - "Total cystectomy of HCE appears to be safe and effective in selected patients with unique, small-sized, superficially located cysts. "
12/01/2015 - "At a level of 0.00125%, PHMB had no significant CPEs on HCE cells, whereas 100 μM DCB and 10 μM isoxaben significantly inhibited the formation of the inner cyst wall of Acanthamoeba during encystation, and Acanthamoeba trophozoites failed to convert into mature cysts. "
12/01/2010 - "Up to one-third of HCE can be shown their complications such as rupture of the cyst, secondary infection, and anaphylactic reaction. "
01/01/1994 - "The aim of this work was to investigate pharmacological properties attempting to elucidate the efficacy of HCE in chronic venous insufficiency. "
05/01/1996 - "Oxerutins (O-(beta-hydroxyethyl)rutosides, HR, Venoruton) and horse chestnut extract (HCE) are active principles of first priority for the pharmacological treatment of chronic venous insufficiency (CVI). "
|1.||Collagen Type XVIII (Type XVIII Collagen)
|4.||Ophthalmic Solutions (Eye Drops)
|7.||dorzolamide-timolol combination (Cosopt)
|2.||Angioplasty (Angioplasty, Transluminal)
|3.||Corneal Transplantation (Keratoplasty)
|4.||Homologous Transplantation (Allograft)
|5.||Surgical Portasystemic Shunt (Portosystemic Shunt)